BIONTECH SE-ADR (BNTX) Stock News
NASDAQ:BNTX - Nasdaq - US09075V1026 - ADR - Currency: USD
BNTX Latest News, Press Relases and Analysis
Market Monitor News June 13 (Oracle UP - Gamestop DOWN)
U.S. stocks edge higher as inflation cools, Oracle soars on AI growth, and markets brace for Israel-Iran conflict escalation.
Market Monitor News June 03 (Cleveland-Cliffs, Blueprint Medicines UP - First Solar DOWN)
Wall Street Climbs Despite Trade Tensions: Steel Stocks Shine, Apple Impresses
Stock market today: Dow, S&P 500, Nasdaq drift higher, dollar slides amid renewed tariff threats
Wholesale data showed milder inflationary pressures while Trump renewed his threat to impose "take it or leave it" tariffs on trading partners.
BioNTech bolsters mRNA pipeline with $1.25bn CureVac acquisition
The transaction will see BioNTech assimilate its former rival in the Covid-19 vaccine arena.
Mentions: CVAC
Oracle's Strong Results, Guidance Increase Outweigh Margin Concerns, UBS Says
Oracle's (ORCL) strong fiscal fourth-quarter results and its increased revenue outlook are expected
Top Stock Movers Now: Oracle, Boeing, CureVac, and More
U.S. equities were mixed and little changed at midday as a second inflation report this week came in lower than anticipated.
Stock market today: S&P 500, Nasdaq little changed amid renewed tariff threats, Boeing stock weighs on Dow
Wholesale data showed milder inflationary pressures, even as Trump renewed his threat to impose "take it or leave it" tariffs on trading partners.
Stock market today: Dow, S&P 500, Nasdaq edge higher amid renewed tariff threats, Boeing stock slumps
Wholesale data showed milder inflationary pressures, even as Trump renewed his threat to impose "take it or leave it" tariffs on trading partners.
Carlyle teams up with Citi to invest in fintech lenders
As part of the partnership, Carlyle and Citi will share market intelligence, and explore co-investment and financing opportunities, the companies added. The rise of fintech lending, fueled by convenient application processes and flexible credit, is pushing traditional financial heavyweights to gain exposure to the space. Facing surging demand from borrowers, fintech lenders are also increasingly turning to investment firms for capital.
COVID-19 Vaccine Maker BioNTech Buys CureVac as It Aims for Cancer Treatments
CureVac shares skyrocketed 35% Thursday when the biotech firm agreed to be bought by COVID-19 vaccine maker BioNTech in an all-stock deal valued at about $1.25 billion.
Mentions: CVAC
Telus offers to fully own digital unit for greater control of AI capabilities
The company has offered $3.40 per share to acquire the shares it does not own in Telus Digital, valuing the unit at $946.8 million, according to Reuters' calculation. Telus currently holds about 57% of the digital unit's outstanding shares directly and through its other units. U.S.-listed shares of the digital unit are down more than 24% this year, severely lagging the parent company whose U.S. listing is up nearly 19% this year.
BioNTech To Acquire CureVac In All-Stock Deal Valued At $1.25B: Retail Sees Breakthrough In Cancer Treatment
Under the terms of the deal, each CureVac share will be exchanged for approximately $5.46 in BioNTech American depositary shares.
Morning Bid: Oil pops, dollar drops
* U.S. President Donald Trump said on Wednesday U.S. personnel were being moved out of the Middle East because "it could be a dangerous place", adding that the United States would not allow Iran to have a nuclear weapon. * U.S. consumer prices increased less than expected in May as cheaper gasoline partially offset higher rents, but inflation is expected to accelerate in the coming months on the back of the Trump administration's import tariffs.
Chime valued at $18.4 billion as shares soar in Nasdaq debut
(Reuters) -Chime Financial's shares surged 59% in their hotly anticipated Nasdaq debut on Thursday, valuing the digital bank at $18.4 billion and extending a winning streak for new stock market listings. If momentum holds in the next few weeks, Chime could reinvigorate confidence among other players in the fintech industry, where valuations have cooled from pandemic-era highs. "If well-received, Chime could help reopen the IPO window for other long-delayed unicorns."
BioNTech takes over CureVac in $1.25 billion all-stock deal among COVID rivals
(Reuters) -German biotech firm BioNTech has agreed to acquire domestic peer CureVac for about $1.25 billion worth of BioNTech shares, it said on Thursday, to boost its work on new mRNA-based cancer treatments. Under the deal, which pairs two former rivals in the race to develop COVID-19 vaccines, CureVac shareholders stand to receive a premium of 55% over the three-month average share price, and leave them with a stake of about 4%-6% in BioNTech, the suitor said. CureVac's Frankfurt-listed shares surged 27% to a five-month high, valuing the company at 1.04 billion euros ($1.2 billion), while BioNTech shares were down 2% by 1237 GMT.
BioNTech Announces Strategic Transaction to Acquire CureVac in Public Exchange Offer
BioNTech Announces Strategic Transaction to Acquire CureVac in Public Exchange Offer
Acquisition will strengthen the research, development, manufacturing and commercialization of mRNA-based cancer immunotherapy candidates, marking...
BioNTech kündigt strategische Transaktion zur Übernahme von CureVac im Rahmen eines öffentlichen Umtauschangebots an
Die geplante Übernahme soll die Forschung, Entwicklung, Herstellung und Kommerzialisierung von mRNA-basierten Krebsimmuntherapie-Kandidaten stärken und ist...
Vertex Presents New Data on the Benefits of ALYFTREK
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is one of the 13 Biotech Stocks with Huge Upside Potential. The company shared new data at the 48th European Cystic Fibrosis Conference, revealing that ALYFTREK® (vanzacaftor/tezacaftor/deutivacaftor) is linked with improved clinical outcomes and quality of life in cystic fibrosis (CF) patients. A pooled research found that sweat chloride (SwCl) levels […]
Global Billion Dollar Oncology Industry Experiencing Substantial Growth Driven by Increasing Cancer Incidences
Stock market today: S&P 500, Nasdaq have records back in sight as stocks gain amid US-China trade talks
The focus in on the second day of US-China trade talks after an upbeat initial meeting.
Stock market today: Dow, S&P 500, Nasdaq edge higher in wait for clues on US-China trade talks
The focus in on the second day of US-China trade talks after an upbeat initial meeting.
Stock market today: Dow, S&P 500, Nasdaq tread water in wait for clues on US-China trade talks
The focus in on the second day of US-China trade talks after an upbeat initial meeting.
Stock market today: Dow, S&P 500, Nasdaq tread water as US-China trade talks enter second day
The focus in on the second day of US-China trade talks after an upbeat initial meeting.
Vaccine Stocks Alert: Has RFK Jr.'s CDC Panel Shakeup Sent Retail Traders To The Sidelines?
Kennedy said the Department of Health and Human Services would retire all 17 current members of the ACIP, citing what he called a "crisis of public trust."
Vaccine Stocks Moderna, Pfizer Hit After A Surprise Blow From RFK Jr.
A CDC committee in charge of making vaccine recommendations was gutted Monday to make way for a new coalition.
BMY Collaborates for Oncology Drug: Will This Boost Its Portfolio?
BMY teams with BioNTech on BNT327, a dual-target cancer therapy, as legacy drugs face mounting generic pressure
Why UWM Holdings Corp. (UWMC) Crashed On Monday
We recently published a list of These 10 Stocks Already Sank in June. In this article, we are going to take a look at where UWM Holdings Corp. (NYSE:UWMC) stands against other worst performers on Monday. UWM Holdings dropped its share prices by 4.88 percent on Monday to finish at $4.09 apiece, as investors repositioned portfolios […]
Why Peloton Interactive, Inc. (PTON) Crashed On Monday
We recently published a list of These 10 Stocks Already Sank in June. In this article, we are going to take a look at where Peloton Interactive, Inc. (NASDAQ:PTON) stands against other worst performers on Monday. Peloton extended its losing streak to a fourth consecutive day on Monday, dropping 7.04 percent to finish at $6.6 apiece […]
Stock market today: Dow, S&P 500, Nasdaq close higher as US-China trade tensions flare up
China added fuel to simmering trade tensions with the US, setting investors on guard as they turned the page on a bullish May.
Why BioNTech Stock Soared Today
Bristol Myers Squibb just agreed to shower BioNTech with cash.